Obio Technology (Shanghai) Corp., Ltd., a biotechnology company, focuses on the development of gene therapy vectors in China. The company provides gene function and gene therapy research, and other CRO services, such as drug target and drug efficacy research. It also offers CDMO services, such as process development and testing, IND-CMC pharmaceutical research, and clinical sample GMP production for the research and development of genetic drugs. The company was founded in 2013 and is headquartered in Shanghai, China.
Stock data | 2024 | Change |
---|---|---|
Price | $0.5952464912899358 | N/A |
Market Cap | $385.38M | N/A |
Shares Outstanding | 647.43M | N/A |
Employees | 741.00 | N/A |